ArticleFrontiers in pharmacology2025

Barriers to glucagon-like peptide-1 agonists used for obesity management among the general population in Tabuk City, Saudi Arabia, and their relation to smoking cessation and antidepressants.

Amirah Alhowiti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.